Zentalis Pharmaceuticals, Inc. (ZNTL) ownership: Top institutional holder: 5AM Venture Management, LLC ($9.24M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| 5AM Venture Management, LLC | 3947913.00 | $9.24M | 2026-03-31 |
| Squadron Capital Management LLC | 3631000.00 | $8.50M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 2956526.00 | $6.92M | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 2848252.00 | $6.66M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2310707.00 | $5.41M | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1938145.00 | $4.54M | 2026-03-31 |
| CITADEL ADVISORS LLC | 1732083.00 | $4.05M | 2026-03-31 |
| VANGUARD GROUP INC | 2855590.00 | $3.86M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-08-14 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-05-26 | |
| Sell | null | 2026-05-26 |
Back to ZNTL overview · ZNTL earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.